Kang Li
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Kang Li has a total of 42 co-authors. Here are the top co-authors by number of shared publications:
Ben-Cheng Lin
Institute of Environmental and Operational Medicine, Academy of Military Medical Sciences, Academy of Military Sciences, Tianjin 300050, China
1 shared publication- Bingyu Liang
Guangxi Key Laboratory of AIDS Prevention and Treatment, School of Public Health, Guangxi Medical University, Nanning, China
1 shared publication - Chaozhi Jin
State Key Laboratory of Proteomics, Beijing Proteome Research Center, National Center for Protein Sciences (Beijing), Beijing Institute of lifeomics, Beijing 102206, China
1 shared publication - Chuanyi Ning
School of Nursing, Guangxi Medical University, Nanning, China
1 shared publication Dianhui Wu
1 shared publicationFaming Pan
Department of Epidemiology and Biostatistics, School of Public Health, Anhui Medical University, Hefei, China
1 shared publication
Latest Publications
- 19 September 2024
- Published by Elsevier in Food Bioscience
- Vol. 62
Optimization of fermentation conditions and analysis of the changes in flavor compounds for lemon vinegar
- 19 September 2024
- Published by Elsevier in Food Bioscience
- Vol. 62
Optimization of fermentation conditions and analysis of the changes in flavor compounds for lemon vinegar
- 1 September 2022
- Vol. 38 (3) , 258-263
[Effects of ozone sub-chronic exposure on lncRNA expression profiles in rat heart].
Objective: This article aims to observe the changes in long noncoding RNA (lncRNA) expression profiles in rat hearts after ozone sub-chronic exposure. To provide scientific data to explore the role and mechanism of differentially expressed lncRNA in damaged hearts caused by ozone sub-chronic exposure. Methods: Eighteen Wistar rats were randomly divided into filtered air and ozone exposure groups, with nine rats in each group. The rats in filtered air group were exposed to filtered air, while the rats in ozone exposure group were exposed to ozone at 0.5 ppm(0.980 mg/m3)for 90 days at a frequency of 6 hours per day. After ozone exposure, cardiac tissues were collected and the total RNA was extracted. The expression level of lncRNA in the hearts of two groups was detected by microarray and qRT-PCR method and the potential functions of the differentially expressed lncRNA were analyzed by bioinformatics. Results: Compared with the filtered air group, lncRNA's expression profile was significantly altered in the rat hearts of ozone exposure group. A total of 167 lncRNA were up-regulated significantly and 64 lncRNA were down-regulated significantly. GO analysis indicated that the up-regulated lncRNA might involve in the process of regulating growth and development, and the down-regulated lncRNA might participate in nutrient catabolic. KEGG results showed that the up-regulated lncRNA might be involved in regulating the PI3K-Akt signaling pathway. The down-regulated lncRNA might regulate the metabolic processes of various vitamins and main energy-supplying substances. Conclusion: Ozone sub-chronic exposure can cause changes in the expression profile of lncRNA in rat hearts, which may regulate the effects of ozone sub-chronic exposure on the heart through the metabolism of energy and nutrients.
- 1 September 2022
- Vol. 38 (3) , 258-263
[Effects of ozone sub-chronic exposure on lncRNA expression profiles in rat heart].
Objective: This article aims to observe the changes in long noncoding RNA (lncRNA) expression profiles in rat hearts after ozone sub-chronic exposure. To provide scientific data to explore the role and mechanism of differentially expressed lncRNA in damaged hearts caused by ozone sub-chronic exposure. Methods: Eighteen Wistar rats were randomly divided into filtered air and ozone exposure groups, with nine rats in each group. The rats in filtered air group were exposed to filtered air, while the rats in ozone exposure group were exposed to ozone at 0.5 ppm(0.980 mg/m3)for 90 days at a frequency of 6 hours per day. After ozone exposure, cardiac tissues were collected and the total RNA was extracted. The expression level of lncRNA in the hearts of two groups was detected by microarray and qRT-PCR method and the potential functions of the differentially expressed lncRNA were analyzed by bioinformatics. Results: Compared with the filtered air group, lncRNA's expression profile was significantly altered in the rat hearts of ozone exposure group. A total of 167 lncRNA were up-regulated significantly and 64 lncRNA were down-regulated significantly. GO analysis indicated that the up-regulated lncRNA might involve in the process of regulating growth and development, and the down-regulated lncRNA might participate in nutrient catabolic. KEGG results showed that the up-regulated lncRNA might be involved in regulating the PI3K-Akt signaling pathway. The down-regulated lncRNA might regulate the metabolic processes of various vitamins and main energy-supplying substances. Conclusion: Ozone sub-chronic exposure can cause changes in the expression profile of lncRNA in rat hearts, which may regulate the effects of ozone sub-chronic exposure on the heart through the metabolism of energy and nutrients.
- Open Access
- 25 February 2022
- Published by Wolters Kluwer Health in Medicine
- Vol. 101 (8) , e28891
Comparison of cyclophosphamide and calcineurin inhibitors for idiopathic membranous nephropathy
Background: Idiopathic membranous nephropathy (IMN) is one of the leading causes of nephrotic syndrome in adults. We performed a protocol for systematic review and meta-analysis to compare the efficacy and safety of cyclophosphamide (CTX) with calcineurin inhibitors (CNIs) in the treatment of IMN. Methods: PubMed, EMBASE, Cochrane Central Register of Controlled Trials, and 3 Chinese databases (WanFang Data, Chongqing VIP and China National Knowledge Infrastructure) were searched from inception through January 2022 to identify randomized controlled trials that compared CTX with CNIs for patients with IMN. Systematic review and meta-analysis of the data will be performed in RevMan software (version 5.3) according to the preferred reporting items of systematic reviews and meta-analysis guidelines. Two authors independently performed the literature searching, data extraction, and quality evaluation. Risk of bias was assessed using the Cochrane Risk of Bias Tool for randomized controlled trials. Results: The results will be submitted to a peer-reviewed journal once completed. Conclusion: The conclusion of our research will provide evidence to help physicians to decide between CTX and CNIs therapy regimens for IMN patients. Open Science Framework registration number: 10.17605/OSF.IO/G584K
- 25 February 2022
- Published by Wolters Kluwer Health in Medicine
- Vol. 101 (8) , e28891
Open AccessComparison of cyclophosphamide and calcineurin inhibitors for idiopathic membranous nephropathy
Background: Idiopathic membranous nephropathy (IMN) is one of the leading causes of nephrotic syndrome in adults. We performed a protocol for systematic review and meta-analysis to compare the efficacy and safety of cyclophosphamide (CTX) with calcineurin inhibitors (CNIs) in the treatment of IMN. Methods: PubMed, EMBASE, Cochrane Central Register of Controlled Trials, and 3 Chinese databases (WanFang Data, Chongqing VIP and China National Knowledge Infrastructure) were searched from inception through January 2022 to identify randomized controlled trials that compared CTX with CNIs for patients with IMN. Systematic review and meta-analysis of the data will be performed in RevMan software (version 5.3) according to the preferred reporting items of systematic reviews and meta-analysis guidelines. Two authors independently performed the literature searching, data extraction, and quality evaluation. Risk of bias was assessed using the Cochrane Risk of Bias Tool for randomized controlled trials. Results: The results will be submitted to a peer-reviewed journal once completed. Conclusion: The conclusion of our research will provide evidence to help physicians to decide between CTX and CNIs therapy regimens for IMN patients. Open Science Framework registration number: 10.17605/OSF.IO/G584K
- Open Access
- 1 February 2020
- Published by SAGE Publications in AIDS Research and Human Retroviruses
- Vol. 36 (2) , 143-152
Characterization of a Novel HIV-1 Recombinant Form (CRF01_AE/CRF07_BC/CRF08_BC) Identified from Guangxi, China
Recently, more and more kinds of circulating forms (CRFs) and unique recombinant forms (URFs) identified in the population in China. A novel HIV-1 recombinant virus (2016GXNNIDU016) was identified in this study, which was isolated from an HIV-1 infected intravenous drug user in Nanning, the capital of Guangxi, China. Phylogenetic analysis of the near full-length genome (NFLG) indicated that the sequence (2016GXNNIDU016) was a monophyletic branch that did not cluster with any previously identified genotype. Recombinant analysis showed that the NFLG of 2016GXNNIDU016 is composed of CRF07_BC, CRF01_AE and CRF08_BC, including nine mosaic segments. Differing from previously documented CRF01_AE and CRF07/08_BC recombinant forms, 2016GXNNIDU016 increases the genetic complexity of HIV-1 in Guangxi. The constant emergence of novel recombinant forms should draw our attention to make more efforts in supervising and preventing the spread of HIV infection.
- 1 February 2020
- Published by SAGE Publications in AIDS Research and Human Retroviruses
- Vol. 36 (2) , 143-152
Open AccessCharacterization of a Novel HIV-1 Recombinant Form (CRF01_AE/CRF07_BC/CRF08_BC) Identified from Guangxi, China
Recently, more and more kinds of circulating forms (CRFs) and unique recombinant forms (URFs) identified in the population in China. A novel HIV-1 recombinant virus (2016GXNNIDU016) was identified in this study, which was isolated from an HIV-1 infected intravenous drug user in Nanning, the capital of Guangxi, China. Phylogenetic analysis of the near full-length genome (NFLG) indicated that the sequence (2016GXNNIDU016) was a monophyletic branch that did not cluster with any previously identified genotype. Recombinant analysis showed that the NFLG of 2016GXNNIDU016 is composed of CRF07_BC, CRF01_AE and CRF08_BC, including nine mosaic segments. Differing from previously documented CRF01_AE and CRF07/08_BC recombinant forms, 2016GXNNIDU016 increases the genetic complexity of HIV-1 in Guangxi. The constant emergence of novel recombinant forms should draw our attention to make more efforts in supervising and preventing the spread of HIV infection.
- Open Access
- 18 November 2017
- Published by Impact Journals, LLC in Oncotarget
- Vol. 8 (64) , 107565-107576
Effect modification by region in the associations ofLEP G2548AandLEPR Q223Rpolymorphisms with statin-induced CK elevation
// <![CDATA[ $('.header-date').hide();$('#titleAuthors').hide();$('#abstractHeader').hide(); // ]]> Shanqun Jiang1, 2, Scott A. Venners3, Kang Li1, Yi-Hsiang Hsu4, 5, Justin Weinstock6, Yanfeng Zou7, Faming Pan7 and Xiping Xu2, 8 1School of Life Sciences, Anhui University, Hefei, China 2Institute of Biomedicine, Anhui Medical University, Hefei, China 3Faculty of Health Sciences, Simon Fraser University, Burnaby, BC, Canada 4Institute for Aging Research, HSL and Harvard Medical School, Boston, MA, USA 5Molecular and Integrative Physiological Sciences Program, Harvard School of Public Health, Boston, MA, USA 6Department of Statistics, University of Virginia, Charlottesville, VA, USA 7Department of Epidemiology and Biostatistics, School of Public Health, Anhui Medical University, Hefei, China 8Division of Epidemiology and Biostatistics, University of Illinois at Chicago School of Public Health, Chicago, IL, USA Correspondence to: Shanqun Jiang, email: shanqunjiang2014@163.com Keywords: LEP G2548A; LEPR Q223R; creatine kinase; hyperlipidemia; simvastatin Received: August 24, 2017 Accepted: October 28, 2017 Published: November 18, 2017 ABSTRACT We investigated the associations of LEP G2548A and LEPR Q223R polymorphisms with statin-induced creatine kinase (CK) elevation among Chinese patients with hyperlipidemia. A total of587 enrolled individuals were treated with 20 mg/d oral simvastatin for 8 consecutive weeks. Genotyping of LEP G2548A and LEPR Q223R were conducted using PCR-RFLP. Multiple regression analyses showed that, in the Dongzhi region only, patients carrying the LEP AA genotype had a significantly greater increase in CK levels compared to those carrying the AG+GG genotypes after four weeks (P = 0.004) and eight weeks (P < 0.001) consecutive simvastatin treatment. Patients were further divided into three groups based on the tertiles of the CK distribution. Compared to subjects in the lowest tertile of CK elevation, the adjusted relative odds of having the AG+GG genotypes among subjects in the highest tertile was 0.5 (95% CI, 0.3 to 0.7) and 0.4 (95% CI, 0.2 to 0.6) after the fourth and eighth weeks, respectively. The interaction terms between the Beijing or Dongzhi region and the LEP GA+AA genotypes were marginally significant for CK elevation at the fourth week (P = 0.057) and significant for CK elevation at the eighth week (P = 0.002). The adverse effect of the LEP G2548A polymorphism on increasing CK levels may be dependent on the environmental milieu. It suggests that lifestyle interventions might offset the side effects of simvastatin therapy among those with genetic susceptibility. Further research is needed to identify specific individual-level factors for clinical practice that modify the effect of genotype.
- 18 November 2017
- Published by Impact Journals, LLC in Oncotarget
- Vol. 8 (64) , 107565-107576
Open AccessEffect modification by region in the associations ofLEP G2548AandLEPR Q223Rpolymorphisms with statin-induced CK elevation
// <![CDATA[ $('.header-date').hide();$('#titleAuthors').hide();$('#abstractHeader').hide(); // ]]> Shanqun Jiang1, 2, Scott A. Venners3, Kang Li1, Yi-Hsiang Hsu4, 5, Justin Weinstock6, Yanfeng Zou7, Faming Pan7 and Xiping Xu2, 8 1School of Life Sciences, Anhui University, Hefei, China 2Institute of Biomedicine, Anhui Medical University, Hefei, China 3Faculty of Health Sciences, Simon Fraser University, Burnaby, BC, Canada 4Institute for Aging Research, HSL and Harvard Medical School, Boston, MA, USA 5Molecular and Integrative Physiological Sciences Program, Harvard School of Public Health, Boston, MA, USA 6Department of Statistics, University of Virginia, Charlottesville, VA, USA 7Department of Epidemiology and Biostatistics, School of Public Health, Anhui Medical University, Hefei, China 8Division of Epidemiology and Biostatistics, University of Illinois at Chicago School of Public Health, Chicago, IL, USA Correspondence to: Shanqun Jiang, email: shanqunjiang2014@163.com Keywords: LEP G2548A; LEPR Q223R; creatine kinase; hyperlipidemia; simvastatin Received: August 24, 2017 Accepted: October 28, 2017 Published: November 18, 2017 ABSTRACT We investigated the associations of LEP G2548A and LEPR Q223R polymorphisms with statin-induced creatine kinase (CK) elevation among Chinese patients with hyperlipidemia. A total of587 enrolled individuals were treated with 20 mg/d oral simvastatin for 8 consecutive weeks. Genotyping of LEP G2548A and LEPR Q223R were conducted using PCR-RFLP. Multiple regression analyses showed that, in the Dongzhi region only, patients carrying the LEP AA genotype had a significantly greater increase in CK levels compared to those carrying the AG+GG genotypes after four weeks (P = 0.004) and eight weeks (P < 0.001) consecutive simvastatin treatment. Patients were further divided into three groups based on the tertiles of the CK distribution. Compared to subjects in the lowest tertile of CK elevation, the adjusted relative odds of having the AG+GG genotypes among subjects in the highest tertile was 0.5 (95% CI, 0.3 to 0.7) and 0.4 (95% CI, 0.2 to 0.6) after the fourth and eighth weeks, respectively. The interaction terms between the Beijing or Dongzhi region and the LEP GA+AA genotypes were marginally significant for CK elevation at the fourth week (P = 0.057) and significant for CK elevation at the eighth week (P = 0.002). The adverse effect of the LEP G2548A polymorphism on increasing CK levels may be dependent on the environmental milieu. It suggests that lifestyle interventions might offset the side effects of simvastatin therapy among those with genetic susceptibility. Further research is needed to identify specific individual-level factors for clinical practice that modify the effect of genotype.
- Open Access
- 21 February 2017
- Published by Springer Nature in Scientific Reports
- Vol. 7 (1) , 43143
Human enterovirus 71 protein interaction network prompts antiviral drug repositioning
As a predominant cause of human hand, foot, and mouth disease, enterovirus 71 (EV71) infection may lead to serious diseases and result in severe consequences that threaten public health and cause widespread panic. Although the systematic identification of physical interactions between viral proteins and host proteins provides initial information for the recognition of the cellular mechanism involved in viral infection and the development of new therapies, EV71-host protein interactions have not been explored. Here, we identified interactions between EV71 proteins and host cellular proteins and confirmed the functional relationships of EV71-interacting proteins (EIPs) with virus proliferation and infection by integrating a human protein interaction network and by functional annotation. We found that most EIPs had known interactions with other viruses. We also predicted ATP6V0C as a broad-spectrum essential host factor and validated its essentiality for EV71 infection in vitro. EIPs and their interacting proteins were more likely to be targets of anti-inflammatory and neurological drugs, indicating their potential to serve as host-oriented antiviral targets. Thus, we used a connectivity map to find drugs that inhibited EIP expression. We predicted tanespimycin as a candidate and demonstrated its antiviral efficiency in vitro. These findings provide the first systematic identification of EV71-host protein interactions, an analysis of EIP protein characteristics and a demonstration of their value in developing host-oriented antiviral therapies.
- 21 February 2017
- Published by Springer Nature in Scientific Reports
- Vol. 7 (1) , 43143
Open AccessHuman enterovirus 71 protein interaction network prompts antiviral drug repositioning
As a predominant cause of human hand, foot, and mouth disease, enterovirus 71 (EV71) infection may lead to serious diseases and result in severe consequences that threaten public health and cause widespread panic. Although the systematic identification of physical interactions between viral proteins and host proteins provides initial information for the recognition of the cellular mechanism involved in viral infection and the development of new therapies, EV71-host protein interactions have not been explored. Here, we identified interactions between EV71 proteins and host cellular proteins and confirmed the functional relationships of EV71-interacting proteins (EIPs) with virus proliferation and infection by integrating a human protein interaction network and by functional annotation. We found that most EIPs had known interactions with other viruses. We also predicted ATP6V0C as a broad-spectrum essential host factor and validated its essentiality for EV71 infection in vitro. EIPs and their interacting proteins were more likely to be targets of anti-inflammatory and neurological drugs, indicating their potential to serve as host-oriented antiviral targets. Thus, we used a connectivity map to find drugs that inhibited EIP expression. We predicted tanespimycin as a candidate and demonstrated its antiviral efficiency in vitro. These findings provide the first systematic identification of EV71-host protein interactions, an analysis of EIP protein characteristics and a demonstration of their value in developing host-oriented antiviral therapies.
- Open Access
- 1 May 2003
- Published by Elsevier in Journal of Biological Chemistry
- Vol. 278 (19) , 16797-16801
Calcineurin/Nuclear Factors of Activated T Cells (NFAT)-activating and Immunoreceptor Tyrosine-based Activation Motif (ITAM)-containing Protein (CNAIP), a Novel ITAM-containing Protein That Activates the Calcineurin/NFAT-signaling Pathway
- 1 May 2003
- Published by Elsevier in Journal of Biological Chemistry
- Vol. 278 (19) , 16797-16801
Open AccessCalcineurin/Nuclear Factors of Activated T Cells (NFAT)-activating and Immunoreceptor Tyrosine-based Activation Motif (ITAM)-containing Protein (CNAIP), a Novel ITAM-containing Protein That Activates the Calcineurin/NFAT-signaling Pathway